Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.

Sarkis S, Belrose G, Peloponese JM Jr, Olindo S, Césaire R, Mesnard JM, Gross A.

J Clin Virol. 2013 Sep;58(1):295-8. doi: 10.1016/j.jcv.2013.05.006. Epub 2013 Jun 4.

PMID:
23756056
2.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

4.

IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Best I, López G, Verdonck K, González E, Tipismana M, Gotuzzo E, Vanham G, Clark D.

Immunology. 2009 Sep;128(1 Suppl):e777-86. doi: 10.1111/j.1365-2567.2009.03082.x. Epub 2009 Feb 17.

6.

Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.

Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.

J Infect Dis. 2001 Mar 15;183(6):857-64. Epub 2001 Feb 13.

PMID:
11237801
7.

Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S.

Blood. 2002 Jan 1;99(1):88-94.

8.

Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.

de Souza JG, da Fonseca FG, Martins ML, Martins CP, de Carvalho LD, Coelho-dos-Reis JG, Carneiro-Proietti AB, Martins-Filho OA, Barbosa-Stancioli EF; GIPH.

J Clin Virol. 2011 Jan;50(1):13-8. doi: 10.1016/j.jcv.2010.09.007. Epub 2010 Oct 15.

PMID:
20951636
9.

Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.

Medina F, Quintremil S, Alberti C, Godoy F, Pando ME, Bustamante A, Barriga A, Cartier L, Puente J, Tanaka Y, Valenzuela MA, Ramírez E.

J Med Virol. 2016 Mar;88(3):521-31. doi: 10.1002/jmv.24342. Epub 2015 Oct 19.

PMID:
26241614
10.

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.

Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, Teixeira-Carvalho A, Peruhype-Magalhães V, Carneiro-Proietti AB.

Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. Review.

PMID:
18691139
11.

Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.

Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N.

Hum Immunol. 2011 Nov;72(11):1001-6. doi: 10.1016/j.humimm.2011.07.308. Epub 2011 Aug 2.

PMID:
21851845
12.

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.

Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1705-9.

PMID:
11080814
13.
14.

In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y.

Retrovirology. 2009 Feb 19;6:19. doi: 10.1186/1742-4690-6-19.

15.

Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.

Kozako T, Akimoto M, Toji S, White Y, Suzuki S, Arima T, Suruga Y, Matsushita K, Shimeno H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N.

J Med Virol. 2011 Mar;83(3):501-9. doi: 10.1002/jmv.21985.

PMID:
21264872
17.

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Saito M, Tanaka R, Arishima S, Matsuzaki T, Ishihara S, Tokashiki T, Ohya Y, Takashima H, Umehara F, Izumo S, Tanaka Y.

Retrovirology. 2013 May 7;10:51. doi: 10.1186/1742-4690-10-51.

18.
19.

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalhães E, Melo A, Dutra WO, Gollob KJ, Carvalho EM.

BMC Infect Dis. 2004 Mar 2;4:7.

20.

Supplemental Content

Support Center